These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3708145)

  • 21. Acceptor site(s) for T cell-replacing factor (TRF) on B lymphocytes. II. Activation of B cells by cross-linkage or aggregation of the TRF acceptor molecule.
    Tominaga A; Takatsu K; Hamaoka T
    J Immunol; 1982 Jun; 128(6):2581-5. PubMed ID: 6978908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Identification of human platelet specific functional antibody and its fragments].
    Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Zhang F; Wang L
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3464-8. PubMed ID: 16686061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facb rosette-forming cells in mice: studies on their functional significance.
    Eales LJ; Hall ND; Hunneyball IM
    Immunology; 1984 May; 52(1):17-24. PubMed ID: 6201437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of the immune response. VII. In vitro immunosuppression by F(ab') 2 or intact IgG antibodies.
    Lees RK; Sinclair NR
    Immunology; 1973 Apr; 24(4):735-50. PubMed ID: 4574800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticore endotoxin F(ab')2 equine immunoglobulin fragments protect against lethal effects of gram-negative bacterial sepsis.
    Dunn DL; Mach PA; Condie RM; Cerra FB
    Surgery; 1984 Aug; 96(2):440-6. PubMed ID: 6379963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of complement amplification by F(ab')(2)-containing immune complexes and naturally occurring anti-hinge antibodies, possible role in systemic inflammation.
    Lutz HU; Fumia S
    Autoimmun Rev; 2008 Jun; 7(6):508-13. PubMed ID: 18558371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-CD3 epsilon F(ab')2 fragments inhibit T cell expansion in vivo during graft-versus-host disease or the primary immune response to nominal antigen.
    Blazar BR; Jenkins MK; Taylor PA; White J; Panoskaltsis-Mortari A; Korngold R; Vallera DA
    J Immunol; 1997 Dec; 159(12):5821-33. PubMed ID: 9550378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the F(ab')2 and Fab' fragments prepared from a mouse monoclonal insulin antibody.
    Diaz-Alonso JM; Kohnert KD; Witt S; Ziegler M
    Allerg Immunol (Leipz); 1990; 36(2):95-101. PubMed ID: 2118298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunospecific targeting of immunoliposomes, F(ab')2 and IgG to red blood cells in vivo.
    Peeters PA; Oussoren C; Eling WM; Crommelin DJ
    Biochim Biophys Acta; 1988 Aug; 943(2):137-47. PubMed ID: 3401475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum type A toxin neutralisation by specific IgG and its fragments: a comparison of mouse systemic toxicity and local flaccid paralysis assays.
    Jones RG; Alsop TA; Hull R; Tierney R; Rigsby P; Holley J; Sesardic D
    Toxicon; 2006 Sep; 48(3):246-54. PubMed ID: 16870221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological enhancement of a murine tumor allograft by passive alloantibody IgG and F(ab')2.
    Kaliss N; Sinclair NR; Cantrell JL
    Eur J Immunol; 1976 Jan; 6(1):38-42. PubMed ID: 971718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to make bispecific antibodies.
    French RR
    Methods Mol Med; 2000; 40():333-9. PubMed ID: 21337104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a human granulocyte functional antigen (GFA-2) involved in antibody-dependent cell-mediated cytotoxicity and phagocytosis.
    López AF; Begley G; Andrews P; Butterworth AE; Vadas MA
    J Immunol; 1985 Jun; 134(6):3969-77. PubMed ID: 3989303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The Fc region of immunoglobulin suppresses atherosclerosis in apolipoprotein E knockout mice].
    Yuan ZY; Liu Y; Kishimoto C; Shioji K; Yokode M; Liu ZQ
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(6):489-93. PubMed ID: 12887764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiopropyl-agarose as a solid phase reducing agent for chemical modification of IgG and F(ab')2.
    Ferraz N; Leverrier J; Batista-Viera F; Manta C
    Biotechnol Prog; 2008; 24(5):1154-9. PubMed ID: 19194926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD3 directed bispecific antibodies induce increased lymphocyte-endothelial cell interactions in vitro.
    Molema G; Tervaert JW; Kroesen BJ; Helfrich W; Meijer DK; de Leij LF
    Br J Cancer; 2000 Jan; 82(2):472-9. PubMed ID: 10646907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F(ab')2 in mice.
    Lu J; Guo Z; Pan X; Wang G; Zhang D; Li Y; Tan B; Ouyang L; Yu X
    Respir Res; 2006 Mar; 7(1):43. PubMed ID: 16553963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
    Welfringer F; d'Athis P; Scherrmann JM; Hervé F
    J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preliminary lymphocyte activation by a mitogen as a condition for demonstrating the ability of the Fab-fragment of normal IgG to inhibit lymphocyte transformation].
    Margulis GU; Baranova FS; Kul'berg AIa
    Biull Eksp Biol Med; 1979 Feb; 87(2):182-4. PubMed ID: 570437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of asymmetric non-precipitating antibody: presence of a carbohydrate residue in only one Fab region of the molecule.
    Labeta MO; Margni RA; Leoni J; Binaghi RA
    Immunology; 1986 Feb; 57(2):311-7. PubMed ID: 3081439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.